Latest Posts

Biotecan SARS-Cov-2 nucleic acid detection—provide a protective barrier for elderly people

Recently, Biotecan screened the staffs from more than 70 community pension service institutions in Pudong New Area, Shanghai for SARS-Cov-2 by nucleic acid detection. This task was commissioned by the Shanghai Civil Affairs Bureau.

24 June 2020

[BIOTECAN]

Precise Prevention and Control of COVID-19, BIOTECAN is always in action

Recently, Beijing has continually reported a number of local new confirmed and asymptomatic infected cases of COVID-19.

24 June 2020

[BIOTECAN]

Taking on the sentinel mission and improving precise prevention and control

Recently, COVID-19 cluster infections have arisen in Beijing. Several new COVID-19 confirmed cases and asymptomatic infections has reported, suggesting that the epidemic control is still at a crucial stage and the work shouldn’t slack off.

24 June 2020

[BIOTECAN]

Zhaolin Zhuang, Mayor of Xuzhou City, Jiangsu Province and his delegation visited Shanghai Biotecan

On the morning of June 16, Zhaolin Zhuang, Mayor of Xuzhou Municipal People's Government of Jiangsu Province led Vice Mayor Donghai Xu, Secretary of Quanshan District Committee Li Yong and leaders of municipal government office

17 June 2020

[BIOTECAN]

Included in the export white list of anti-epidemic materials of the Ministry of Commerce

On June 1, Biotecan entered the list of medical materials manufacturers that had obtained foreign standard certification or registration, which was published on the official website of China Chamber of Commerce for Import & Export of Medicines & Health products.

2 June 2020

[BIOTECAN]

Certificates of National High-tech Enterprises were conferred on Shanghai Biotecan pharmaceuticals

Good News! Certificates of National High-tech Enterprises were conferred on Shanghai Biotecan pharmaceuticals Co.,Ltd and Shanghai Biotecan Medical Laboratory Co.,Ltd.

6 May 2020

[BIOTECAN]

Biotecan has become the novel coronavirus nucleic acid testing institution designated

Biotecan has become the novel coronavirus nucleic acid testing institution designated by Shanghai Municipal Health Commission

6 May 2020

[BIOTECAN]

Turnkey Solution of Novel coronavirus(SARS-CoV-2)precise detection laboratory

Panoramic Laboratory of intelligent pathogen molecular diagnosis

24 April 2020

[BIOTECAN]

Biotecan obtained the accreditation of ISO 13485:2016 Quality Management System

On April 22th,2020,Shanghai Biotecan Pharmaceuticals Co., Ltd passed the authorization and the audit of the ISO13485:2016 Quality Management System, and obtained the certificate of accreditation for medical instruments.

23 April 2020

[BIOTECAN]

Xiaochun Lu, the chief of Shanghai Municipal Commission of Economy and Informatization visited Biote

On the afternoon of April 15, Mr. Xiaochun Lu, the chief of Shanghai Municipal Commission of Economy and Informatization paid a visit to the Biotecan Pharmaceuticals Company to conduct an intensive investigation of its contribution to the fight against novel coronavirus epidemic

16 April 2020

[BIOTECAN]

Label theme
SARS